Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals’ perspectives on cancer care and artificial intelligence
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Background: The integration of Artificial Intelligence (AI) technology in cancer care has gained unprecedented global attention over the past few decades. This has impacted the way that cancer care is practiced and delivered across settings. The purpose of this study was to explore the perspectives and experiences of healthcare professionals (HCPs) on cancer treatment and the need for AI. This study is a part of the INCISIVE European Union H2020 project's development of user requirements, which aims to fully explore the potential of AI-based cancer imaging technologies. Methods: A mixed-methods research design was employed. HCPs participating in cancer care in the UK, Greece, Italy, Spain, Cyprus, and Serbia were first surveyed anonymously online. Twenty-seven HCPs then participated in semi-structured interviews. Appropriate statistical method was adopted to report the survey results by using SPSS. The interviews were audio recorded, verbatim transcribed, and then thematically analysed supported by NVIVO. Results: The survey drew responses from 95 HCPs. The occurrence of diagnostic delay was reported by 56% (n = 28/50) for breast cancer, 64% (n = 27/42) for lung cancer, 76% (n = 34/45) for colorectal cancer and 42% (n = 16/38) for prostate cancer. A proportion of participants reported the occurrence of false positives in the accuracy of the current imaging techniques used: 64% (n = 32/50) reported this for breast cancer, 60% (n = 25/42) for lung cancer, 51% (n = 23/45) for colorectal cancer and 45% (n = 17/38) for prostate cancer. All participants agreed that the use of technology would enhance the care pathway for cancer patients. Despite the positive perspectives toward AI, certain limitations were also recorded. The majority (73%) of respondents (n = 69/95) reported they had never utilised technology in the care pathway which necessitates the need for education and training in the qualitative finding; compared to 27% (n = 26/95) who had and were still using it. Most, 89% of respondents (n = 85/95) said they would be opened to providing AI-based services in the future to improve medical imaging for cancer care. Interviews with HCPs revealed lack of widespread preparedness for AI in oncology, several barriers to introducing AI, and a need for education and training. Provision of AI training, increasing public awareness of AI, using evidence-based technology, and developing AI based interventions that will not replace HCPs were some of the recommendations. Conclusion: HCPs reported favourable opinions of AI-based cancer imaging technologies and noted a number of care pathway concerns where AI can be useful. For the future design and execution of the INCISIVE project and other comparable AI-based projects, the characteristics and recommendations offered in the current research can serve as a reference.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Healthcare professionals would prefer to see themselves as retaining the overall control of the treatment process of their patients and that AI is used as a decision-support and not a replacement [36, 39, 44, 45], while also acknowledging that AI can also serve as a tool for educational purposes [38] and can lead to more self-assurance in their decisions [43].”
From Healthcare professionals’ perspectives on artificial intelligence in patient care: a systematic review of hindering and facilitating factors on different levels (2025) · cites this paper as [39]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hereby, a facilitating factor is that the outcomes and clinical effectivenes of AI applications should be evidence-based, ideally relying on large randomized controlled trials (RCTs) to support claims about its effectiveness and safety [36, 38, 39, 42, 58], while the development process itself should be transparent [63] and the AI system used should be explainable and verifiable [63].”
From Healthcare professionals’ perspectives on artificial intelligence in patient care: a systematic review of hindering and facilitating factors on different levels (2025) · cites this paper as [39]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Other facilitating factors include the ease of use and user-friendliness of AI technology, ensuring that it is accessible and usable for healthcare professionals [36, 38, 39].”
The cited source says what the claim attributes to it.
In the citing paper
“Five studies reported on the facilitating factors at the indivudual level that encourage greater knowledge about AI by healthcare professionals, including being familiar with AI [34, 37, 38], having time to trial the AI application in their practice [39] and receiving education and training programs [39] as well as conferences and scientific networks [40] as opportunities to learn about them.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Dermatologist-level classification of skin cancer with deep neural networks
Esteva, A., Kuprel, B., Novoa, R. A., Ko, J., Swetter, S. M., Blau, H. M., & Thrun, S. (2017) · Nature · doi:10.1038/nature21056 · Cited by 14,362
Content analysis and thematic analysis: Implications for conducting a qualitative descriptive study
Vaismoradi, M., Turunen, H., & Bondas, T. (2013) · Nursing & Health Sciences · doi:10.1111/nhs.12048 · Cited by 8,327
Qualitative research in health care: Analysing qualitative data
Pope, C. (2000) · BMJ · doi:10.1136/bmj.320.7227.114 · Cited by 8,131 · cited 1×
“Interviews were transcribed verbatim and subsequently analysed thematically using the five-stage framework approach [29, 30] by IH, DB and JK. Transcripts were not returned to participants for comments.”
MethodEysenbach, G. (2004) · Journal of Medical Internet Research · doi:10.2196/jmir.6.3.e34 · Cited by 6,480 · cited 1×
“To ensure standardized reporting of the methods and results of the present online survey, researchers adopted the CHERRIES framework [24].”
MethodQualitative data analysis for applied policy research
(2002) · Analyzing Qualitative Data · doi:10.4324/9780203413081-14 · Cited by 4,964 · cited 1×
“Data analysis Interviews were transcribed verbatim and subsequently analysed thematically using the five-stage framework approach [29, 30] by IH, DB and JK.”
MethodWhat is an adequate sample size? Operationalising data saturation for theory-based interview studies
Francis, J. J., Johnston, M., Robertson, C., Glidewell, L., Entwistle, V., Eccles, M. P., & Grimshaw, J. M. (2010) · Psychology & Health · doi:10.1080/08870440903194015 · Cited by 3,429 · cited 1×
“The stopping criterion indicating data saturation is three interviews which is the number of interviews performed without having new information, after which recruitment can be stopped [28].”
BackgroundArdila, D., Kiraly, A. P., Bharadwaj, S., Choi, B., Reicher, J. J., Peng, L., Tse, D., Etemadi, M., Ye, W., Corrado, G., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0447-x · Cited by 2,167 · cited 1×
“The application of AI in analyzing medical images such as X-rays, mammograms, and CT scans has generated promising results for early detection and classification of different types of cancers, such as breast cancer and lung cancer [34, 35].”
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846 · cited 2×
“Regardless of their development, AI applications in cancer are still considered to be in their infancy [18], which could explain lack of widespread preparedness to their adoption.”
BackgroundResultReed Johnson, F., Lancsar, E., Marshall, D., Kilambi, V., Mühlbacher, A., Regier, D. A., Bresnahan, B. W., Kanninen, B., & Bridges, J. F. P. (2013) · Value in Health · doi:10.1016/j.jval.2012.08.2223 · Cited by 1,799
Research works printed but not linked: 6
- Farina E, Nabhen JJ, Dacoregio MI, Batalini F, Moraes FY. An overview of artificial intelligence in oncology. Vol. 8, Future Science OA. Future Medicine Ltd.; 2022. · DOI · Paper page
- McKinney S, Sieniek M, Godbole V, Nature JG. International evaluation of an AI system for breast cancer screening. nature.com [Internet]. 2020 [cited 2022 Dec 13]; Available from: https://idp.nature.com/authorize/casa?redirect_uri=https://www.nature.com/articles/s41586-019-1799-6
- Zewail A, Saber S. AI-powered analytics in healthcare: enhancing decision-making and efficiency. Int J Appl Health Care Anal. 2023;8(5):1–16.
- Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127–57. · DOI · Paper page
- Hiom SC. Diagnosing cancer earlier: reviewing the evidence for improving cancer survival. nature.com [Internet]. 2015 [cited 2022 Dec 13]; Available from: https://www.nature.com/articles/bjc201523
- Rogers E, Singhal A. Diffusion of innovations. taylorfrancis.com [Internet]. 2014 [cited 2022 Dec 15]; Available from: https://doi.org/10.4324/9780203887011-36/diffusion-innovations-everett-rogers-arvind-singhal-margaret-quinlan · doi:10.4324/9780203887011-36/diffusion-innovations-everett-rogers-arvind-singhal-margaret-quinlan
Cited by
Kumar, Y., Shrivastav, S., Garg, K., Modi, N., Wiltos, K., Woźniak, M., & Ijaz, M. F. (2024) · Scientific Reports · doi:10.1038/s41598-024-75876-2 · Cited by 90
Zapata, R. E., Guerrero, E. J. C., & Montilla, R. E. (2024) · Seminars in Medical Writing and Education · doi:10.56294/mw202449 · Cited by 65
Das, S., Mazumdar, H., Khondakar, K. R., & Kaushik, A. K. (2024) · BMEMat · doi:10.1002/bmm2.12117 · Cited by 65
Alavinejad, M., Shirzad, M., Javid‐Naderi, M. J., Rahdar, A., Fathi‐karkan, S., & Pandey, S. (2025) · Medical Oncology · doi:10.1007/s12032-025-02680-x · Cited by 62
Henzler, D., Schmidt, S., Koçar, A., Herdegen, S., Lindinger, G. L., Maris, M. T., Bak, M. A. R., Willems, D. L., Tan, H. L., Lauerer, M., et al. (2025) · BMC Health Services Research · doi:10.1186/s12913-025-12664-2 · Cited by 54
“• F a m i l i a r i t y [ 34 , 37 , 3 8 ] • T i m e t o t r i a l A I i n p r a c t i c e [ 39 ] • E d u c a t i o n a n d t r a i n i n g [ 39 ] • C o n f e r e n c e s a n d n e t w o r k s [ 40 ] A tt i t u d e t o w a r d s p r o f e ss i o n • N o f e a r o f j o b l o ss [ 41 , 42 ] • I m p r…”
Influential
Metadata
- Authors
- Hesso, I., Kayyali, R., Dolton, D.-R., Joo, K., Zacharias, L., Charalambous, A., Lavdaniti, M., Stalika, E., Ajami, T., Acampa, W., Boban, J., & Nabhani-Gebara, S.
- Affiliations
- Kingston University London (GB)
- University of Turku (FI)
- International Hellenic University (GR)
- Hospital Clínic de Barcelona (ES)
- University of Naples Federico II (IT)
- University of Novi Sad (RS)
- Corresponding author
- Hesso, Iman
- Kayyali, Reem
- Dolton, Debbie-Rose
- Joo, Kwanyoung
- Zacharias, Lithin
- Charalambous, Andreas
- Lavdaniti, Maria
- Stalika, Evangelia
- Ajami, Tarek
- Acampa, Wanda
- Boban, Jasmina
- ORCID
- Venue
- Radiation Oncology
- Published
- 2023-10-09
- Volume
- 18
- Issue
- 1
- Pages
- 167-167
- ISSN
- 1748-717X (ISSN-L)
- PMC
- PMC10561443
- OpenAlex
- W4387454203
- Cited by
- 33
- References
- 56
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 9 · 2023: 1
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Radiation Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UTUPub (University of Turku) (submittedVersion, other-oa)
- UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
- UTUPub (University of Turku) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European commission under the European Union’s Horizon 2020 research and innovation programme (952179)
- Topics
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Artificial Intelligence › AI in cancer detection
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Radiomics and Machine Learning in Medical Imaging
- Keywords
- healthcare professionals' perspectives, delayed diagnosis, cancer care pathway, health technology adoption, Fourth Industrial Revolution, breast cancer, lung cancer, colorectal cancer, prostate cancer
- MeSH terms
- Artificial Intelligence, Breast Neoplasms, Delivery of Health Care, Humans, Lung Neoplasms, Male, Prostatic Neoplasms, Colorectal Neoplasms, Delayed Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals’ perspectives on cancer care and artificial intelligence. https://app.cochat.ai/papers/10.1186/s13014-023-02351-z
- The paper
- Hesso, I., Kayyali, R., Dolton, D.-R., Joo, K., Zacharias, L., Charalambous, A., Lavdaniti, M., Stalika, E., Ajami, T., Acampa, W., Boban, J., & Nabhani-Gebara, S. (2023). Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals’ perspectives on cancer care and artificial intelligence. Radiation Oncology. https://doi.org/10.1186/s13014-023-02351-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.